Flo Health raises US$200m becoming Britain’s latest tech unicorn

The period tracking app Flo Health has secured more than US$200m in funding, making it the first digital consumer women’s health app to achieve unicorn status.

Flo aims to support women during menstruation, conception, pregnancy, and menopause. The app allows users to monitor over 70 symptoms and access various features to track their health.

This latest investment from the US growth equity investor General Atlantic is thought to boost the company’s valuation beyond US$1bn, making it the first digital consumer women’s health app to achieve unicorn status.

“Reaching unicorn status is a significant milestone for Flo and the entire femtech industry,” said Dmitry Gurski, co-founder and CEO of Flo Health.

“When we started Flo, we identified a huge gap in women’s health services. Now, we’re a leader in a global movement to make women’s health a priority everywhere. We’re already helping hundreds of millions of women, and our goal is to reach one billion women through our global pro-social programme.

“This initiative provides free access to Flo Premium across 66 countries, including India, Indonesia, and Nigeria, with nearly 12 million women already benefiting.”

He added: “We’re committed to building a better future for female health, where every woman feels understood and supported, regardless of her location or economic status.

“This investment from General Atlantic will help propel Flo Health’s growth as we continue normalising conversations about women’s health, improving health literacy, and raising awareness of women’s health issues worldwide, especially in underserved regions. ”

According to Gurski, Flo’s partnership with General Atlantic will help position the company for its next phase of growth, with a focus on expanding into new user segments, such as perimenopause and menopause and pursuing expansion opportunities.

Jessie Cai, principal at General Atlantic, commented, “We have been lucky enough to watch the Flo team over the past five years build a beloved, mission-critical app for women globally, and now we have the fortunate opportunity to partner with Dmitry and his team.

We are excited about their big vision and the innovation ahead for the broader women’s health and wellness ecosystem. We believe Flo is a category leader and look forward to leveraging our deep expertise across disruptive consumer technology and subscription platforms to support the company’s continued growth.”

Anna Klepchukova, chief medical officer of Flo Health, added: “This investment accelerates Flo’s mission to revolutionise women’s health.

“With women spending 25 per cent more of their lives in poor health compared to men, we’re committed to changing this unacceptable status quo. As the #1 OB/GYN-recommended cycle tracking app, Flo empowers users with tailored health insights, enabling better-informed conversations with healthcare providers.

“We serve as a tool for preventive care and health education, helping our users recognize potential issues early and encouraging proactive healthcare management. With one in four US women using Flo, our platform is uniquely positioned to bring women’s health into the 21st century, all while maintaining the highest standards of medical credibility, data privacy, and user trust.”

As part of the transaction, Tanzeen Syed, managing director and head of consumer internet and technology at General Atlantic, and Jessie Cai, will join Flo’s board of directors.